✦ LIBER ✦

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

✍ Scribed by P. U. Feig; S. Shah; A. Hermanowski-Vosatka; D. Plotkin; M. S. Springer; S. Donahue; C. Thach; E. J. Klein; E. Lai; K. D. Kaufman

Book ID: 109046118
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 501 KB
Volume: 13
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2011.01375.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overexpression of 11β-Hydroxysteroid Deh

Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients

✍ René Baudrand; Cristian A. Carvajal; Arnoldo Riquelme; Mauricio Morales; Nancy S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

11β-Hydroxysteroid dehydrogenase Type 1:

11β-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle

✍ S. Nair; Y. H. Lee; R. S. Lindsay; B. R. Walker; P. A. Tataranni; C. Bogardus; L 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 171 KB

ChemInform Abstract: 4-(Phenylsulfonamid

ChemInform Abstract: 4-(Phenylsulfonamidomethyl)benzamides as Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1 with Efficacy in Diabetic ob/ob Mice.

✍ Xu Zhang; Zhou Zhou; Huaiyu Yang; Junhua Chen; Ying Feng; Lili Du; Ying Leng; Ji 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Treatment of acute coronary syndromes in

Treatment of acute coronary syndromes in patients with type 2 diabetes mellitus with β-adrenoblockers and angiotensin-converting enzyme inhibitors: cardiohemodynamic effects and impact for prognosis

✍ L. A. Ivanova; S. G. Kanorskii; O. N. Rostovtseva; Basit Halil Sufian; P. A. Gal 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 325 KB